Trials / Not Yet Recruiting
Not Yet RecruitingNCT06637839
Optimal Dosing of High-Intensity Locomotor Training for Step Attainment and Locomotor Outcomes in Stroke Patients Undergoing Acute Inpatient Rehabilitation
A Randomized, Double-blind Study Comparing the Effects of Three Distinct High Intensity Locomotor Training Protocols on Locomotor Outcomes in Subacute Stroke Patients Undergoing Adult Inpatient Rehabilitation.
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 18 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to elucidate optimal dosing for High Intensity Gait Training (HIGT) to reduce locomotor disability for those undergoing inpatient rehabilitation (IR) in the subacute phase of stroke recovery. This is a randomized controlled trial conducted at a single IR facility. Investigators will randomize patients to receive one of two distinct HIGT interventions or a high step count intervention during standard care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Moderate-Intensity Locomotor Training Program | The moderate-intensity program prescribes participants to exert 50-59% of their heart rate (HR) reserve, or a score of 13-15 on Borg's rating of perceived exertion (RPE) scale. |
| BEHAVIORAL | High-Intensity Locomotor Training Program | The high-intensity program prescribes participants to exert at least 60% of their heart rate (HR) reserve, or a score of 16-18 on the RPE scale. |
| BEHAVIORAL | High-Step Count Locomotor Training Program | The high step count program prescribes at least 600 steps per session, at less than 50% or HR reserve, or less than 13 RPE. |
Timeline
- Start date
- 2026-01-01
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2024-10-15
- Last updated
- 2025-09-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06637839. Inclusion in this directory is not an endorsement.